INVA INNOVIVA INC
2026Q1 · CUSIP 45781M101 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
282
Δ holders QoQ
+2
Breadth percentile
Top 53%
Whale holders
147
Δ whales
+6
Inst. holding value
$1.7B
New positions
48
Closed positions
46
Price momentum (1Q)
-8.6%
Put / Call
0/2
Breadth history (34 quarters)
Past Lit Events & Aftermath 6 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q2 | Top 17% | +7.1% | +13.9% |
| 2024Q1 | Top 19% | +16.0% | +18.3% |
| 2022Q1 | Top 11% | -13.7% | -18.0% |
| 2021Q3 | Top 7% | +16.8% | -8.0% |
| 2018Q4 | Top 11% | -2.2% | -20.3% |
| 2018Q1 | Top 7% | -4.0% | +10.6% |
Options Sentiment
Put holders
0
QoQ: 0
Call holders
2
QoQ: +1
See methodology →
Fundamentals
PE (TTM)
3.5
EPS (TTM)
$6.26
EPS YoY
—
Revenue (TTM)
$0.4B
Revenue YoY
+13.8%
Net margin
119.9%
ROE
37.6%
Debt ratio
27.0%
FCF (TTM)
$182M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.